Skip to main content

Table 3 The fractions of various subsets of cells among the CD4 + or CD8 + T cells, or CD19 + B cells

From: Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells

  Controls (n = 18) MS
   Overall (n = 30) RRMS (n = 17) SPMS (n = 6) PPMS (n = 7)
CD21+ in CD4+ T cells 0.41 ± 0.34 0.77 ± 0.76 0.78 ± 0.76 0.79 ± 1.09 0.70 ± 0.42
CD32+ in CD4+ T cells 1.06 ± 0.62 2.85 ± 3.72 a 1.68 ± 1.05 5.97 ± 7.40 a, b 2.86 ± 1.65
CD35+ in CD4+ T cells 5.34 ± 4.74 8.73 ± 8.85 8.33 ± 5.33 5.52 ± 2.15 12.36 ± 16.01
CD21+ in CD8+ T cells 1.16 ± 0.99 2.71 ± 1.86 a 2.07 ± 0.66 4.08 ± 3.33 a 2.92 ± 1.35
CD32+ in CD8+ T cells 3.05 ± 2.52 3.22 ± 3.03 1.88 ± 1.82 2.98 ± 1.95 6.29 ± 3.87 b, c
CD35+ in CD8+ T cells 4.43 ± 1.95 5.43 ± 3.38 5.65 ± 4.48 5.26 ± 1.80 5.23 ± 2.48
CD21+ in CD19+ B cells 84.76 ± 9.66 87.51 ± 6.67 88.13 ± 6.69 86.07 ± 8.20 87.05 ± 5.37
CD32+ in CD19+ B cells 70.02 ± 13.77 66.46 ± 15.42 63.39 ± 16.65 65.90 ± 14.42 74.41 ± 11.67
CD35+ in CD19+ B cells 94.43 ± 4.90 92.63 ± 5.06 93.61 ± 4.58 92.27 ± 1.97 90.57 ± 7.55
  1. Data are presented as mean percentage ± SD.
  2. aP < 0.05 compared to control subjects.
  3. bP < 0.05 compared to RRMS.
  4. cP = 0.051 compared to control subjects.